FR EN
MI COMMUNITY
Veracyte (formerly HaliodDx) is a key player in the MI ecosystem that allows both personalized immunotherapies utilization and acceleration of their development.

Vincent FERT
Veracyte

MI COMMUNITY
The Explore covid-19 project was born from combining the forces of Marseille Immunopôle. It should lead us to better understand this new disease and improve the prognosis of our patients.

Julien CARVELLI
AP-HM

MI COMMUNITY
We and our patients are resolutely committed to the Marseille Immunopôle; patients no longer wish to be simple "providers of biological samples", but full participants in the research process.

Jean-Robert HARLÉ
AMU, AP-HM

MI COMMUNITY
MI today is a great accomplishment as it brings together for the first time all the expertise in immunology but it is above a new strategic step for all Marseille immunology players

Cathy LAPORTE
Marseille Immunopôle

MI COMMUNITY
MI both accelerates research and development in immuno-oncology and offers cancer patients more options in terms of diagnostics and treatments, as well as more innovative clinical trials.

Fabrice BARLESI
Université Paris-Saclay, Gustave Roussy, The Pioneer Project

MI COMMUNITY
“Our immunotherapy antibodies are positioned at the crossroads of two immunology fields with high potential: the γ9δ2 T cells and a novel superfamily of immunomodulators, butyrophilins”

Pierre d’EPENOUX
Imcheck Therapeutics

Newsletter
Stay informed
Subscribe
MI COMMUNITY
Marseille Immunopole is born from the will of all partners to do even better and progress faster, and thus allow patients always to keep one step ahead of the disease.

Éric VIVIER
AMU, AP-HM, CIML, INNATE PHARMA

MI COMMUNITY
MI-mAbs allows researchers to validate the therapeutic potential of their discovery and permits industrials to focus their efforts on the most promising drug candidate

Francois ROMAGNÉ
AMU, MI-mAbs

MI COMMUNITY
Thanks to this unprecedented alliance of researchers, clinicians, technological platforms and industrials we should be able to quickly do much better

Vincent BARLOGIS
AP-HM

MI COMMUNITY
Today Marseille Immunopôle is a great opportunity to challenge our discipline with novel perspectives.

Daniel OLIVE
AMU, IPC, CRCM

Update on the umbrella clinical trial of the PIONeeR project as of August 31, 2023 Read more
MI COMMUNITY
The Pioneer Project draws on the collaborative environment of Marseille Immunopôle, which brings together clinicians, academics and industry players committed to the benefit of patients

Laurent GREILLIER
AP-HM, AMU

MI COMMUNITY
We have developed a library of human tumors xenografted on immunodepressed mice

Michel IOVANNA JUAN
AMU, IPC, CRCM

MI COMMUNITY
Understanding its mechanisms of action and proposing new diagnostic and therapeutic solutions is the ambitious project that we set with my team.

Marcel BLOT-CHABAUD
VRCM

MI COMMUNITY
Together, we pursue a simple goal: to better understand the alterations of energetic metabolism in pancreatic cancer cells

Alice CARRIER
AMU, IPC, CRCM